HIV/AIDS
Researchers from the United Kingdom and United States detail new studies and findings in the area of HIV/AIDS
Published in AIDS Weekly, October 23rd, 2006
Study 1: A phenotypic recessive, post-entry block in rabbit cells causes aberrant trafficking of HIV-1.
According to researchers in England, "Rabbit cells are poorly permissive to HIV-1 infection, but little is known about the nature of this block. We show that the block to infection is mainly at the level of reverse transcription (RT), is independent of the cell receptor used by the virus for entry, cannot be effectively saturated with high doses of virus or virus-like particles, and has a recessive phenotype in human-rabbit heterokaryons."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-23)
More Articles from AIDS Weekly
- HIV/AIDS & Tuberculosis
Tuberculin skin testing sensitivity reduced in patients with HIV infection - HIV/AIDS HAART
Development of HIV-1 resistance is low in patients on tenofovir-containing therapy - HIV/AIDS HAART
Elevated lopinavir and indinavir related to elevated total bilirubin in HIV/AIDS - HIV/AIDS Monitoring
Hemoglobin and ALT levels monitor HAART toxicity in resource-limited settings - HIV/AIDS Transmission
HIV-1 transcytosis across the placenta enhanced by tumor necrosis factor alpha treatment - Business Update
Tibotec announces access program expanded for investigational HIV-1 agent TMC125 - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
